Absci Corporation (ABSI) vs Mineralys Therapeutics, Inc. (MLYS)
- Absci Corporation ABSI 7.58 +1.34%
- Mineralys Therapeutics, Inc. MLYS 14.47 −0.41%
Absci Corporation and Mineralys Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Mineralys Therapeutics, Inc. are of similar size ($1.3B and $1.3B). Mineralys Therapeutics, Inc. has the higher net margin (0.00% vs −8,451.3%) and the higher return on invested capital (0.00% vs −182.0%). Across the 13 metrics below, Mineralys Therapeutics, Inc. leads on 7 and Absci Corporation on 6.
Valuation
Profitability
| Metric | ABSI | MLYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (8,812.31%) | 0.00% | 0.00% |
| Net margin | (8,451.31%) | 0.00% | 0.00% |
| Free cash flow margin | (7,550.91%) | 0.00% | 0.00% |
| Return on equity | (58.59%) | (68.50%) | (50.72%) |
| Return on assets | (51.87%) | (60.15%) | (45.56%) |
| Return on invested capital | (181.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack